tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ANTX Stock Latest News

AN2 Therapeutics downgraded to Hold from Buy at TD Cowen
The FlyAN2 Therapeutics downgraded to Hold from Buy at TD Cowen
1M ago
ANTX
AN2 Therapeutics reports Q3 EPS (43c), consensus (38c)
PremiumThe Fly
AN2 Therapeutics reports Q3 EPS (43c), consensus (38c)
1M ago
ANTX
AN2 Therapeutics Promotes Joshua Eizen to Key Roles
PremiumCompany Announcements
AN2 Therapeutics Promotes Joshua Eizen to Key Roles
2M ago
8K
ANTX
AN2 Therapeutics gets continuation grant to discover novel boron based therapies
PremiumThe Fly
AN2 Therapeutics gets continuation grant to discover novel boron based therapies
2M ago
ANTX
AN2 Therapeutics adopts limited duration stockholder rights plan
PremiumThe Fly
AN2 Therapeutics adopts limited duration stockholder rights plan
4M ago
ANTX
AN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
PremiumThe FlyAN2 Therapeutics reports Q2 EPS (48c), consensus (59c)
4M ago
ANTX
Morning Movers: Iteris skyrockets following take-private agreement
Premium
The Fly
Morning Movers: Iteris skyrockets following take-private agreement
5M ago
CGC
ITI
AN2 Therapeutics downgraded to Underperform from In Line at Evercore ISI
Premium
The Fly
AN2 Therapeutics downgraded to Underperform from In Line at Evercore ISI
5M ago
ANTX
AN2 Therapeutics to terminate Phase 2, Phase 3 parts of EBO-301 trial
PremiumThe Fly
AN2 Therapeutics to terminate Phase 2, Phase 3 parts of EBO-301 trial
5M ago
ANTX
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
AN2 Therapeutics downgraded to Market Perform from Outperform at Leerink
5M ago
ANTX
AN2 Therapeutics price target lowered to $3 from $6 at JMP Securities
PremiumThe Fly
AN2 Therapeutics price target lowered to $3 from $6 at JMP Securities
5M ago
ANTX
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
PremiumCompany Announcements
AN2 Therapeutics Announces Major Restructuring and Cost-Cutting Measures
5M ago
8K
ANTX
Intuit initiated, Charter downgraded: Wall Street’s top analyst calls
PremiumThe FlyIntuit initiated, Charter downgraded: Wall Street’s top analyst calls
6M ago
PR
LPG
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
Premium
The Fly
AN2 Therapeutics price target lowered to $2 from $7 at Evercore ISI
7M ago
ANTX
AN2 Therapeutics reports Q1 EPS (56c), consensus (62c)
Premium
The Fly
AN2 Therapeutics reports Q1 EPS (56c), consensus (62c)
7M ago
ANTX
AN2 Therapeutics upgraded to Outperform from Market Perform at JMP Securities
PremiumThe Fly
AN2 Therapeutics upgraded to Outperform from Market Perform at JMP Securities
9M ago
ANTX
AN2 Therapeutics’ High-Stakes Gamble: Navigating FDA Approval for Epetraborole Amid Clinical Trial Uncertainties
PremiumCompany Announcements
AN2 Therapeutics’ High-Stakes Gamble: Navigating FDA Approval for Epetraborole Amid Clinical Trial Uncertainties
9M ago
ANTX
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
PremiumThe Fly
AN2 Therapeutics reports Q4 EPS (57c), consensus (75c)
9M ago
ANTX
ANTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ANTX Earnings this Week: How Will it Perform?
9M ago
ANTX
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe FlyCantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
10M ago
ANTX
INSM
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
10M ago
ANTX
INSM
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
Premium
The Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
10M ago
ANTX
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >